Global Antidiabetic SGLT-2 Inhibitor Market Research Report 2021

July 2016 | 125 pages | ID: GD580490997EN
QYResearch

Abstracts

This report studies Antidiabetic SGLT-2 Inhibitor in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering

• Anderson Hay & Grain Inc.
• Border Valley
• Sanofi
• Johnson & Johnson
• Bristol-Myers Squibb
• AstraZeneca
• Boehringer Ingelheim
• GlaxoSmithKline
• Pfizer
• Takeda Pharmaceuticals
• Eli Lilly
• Merck & Co.
• Novo Nordisk

Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Antidiabetic SGLT-2 Inhibitor in these regions, from 2011 to 2021 (forecast), like

• North America
• China
• Europe
• Japan
• India

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on sales, market share and growth rate of Antidiabetic SGLT-2 Inhibitor in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Antidiabetic SGLT-2 Inhibitor Market Research Report 2021

1 ANTIDIABETIC SGLT-2 INHIBITOR OVERVIEW

1.1 Product Overview and Scope of Antidiabetic SGLT-2 Inhibitor
1.2 Antidiabetic SGLT-2 Inhibitor Segment by Types
  1.2.1 Global Sales Market Share of Antidiabetic SGLT-2 Inhibitor by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Antidiabetic SGLT-2 Inhibitor Segment by Applications
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Antidiabetic SGLT-2 Inhibitor Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Antidiabetic SGLT-2 Inhibitor (2011-2021)
  1.5.1 Global Antidiabetic SGLT-2 Inhibitor Sales and Revenue (2011-2021)
  1.5.2 Global Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2011-2021)
  1.5.3 Global Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)

2 GLOBAL ANTIDIABETIC SGLT-2 INHIBITOR MARKET COMPETITION BY MANUFACTURERS

2.1 Global Antidiabetic SGLT-2 Inhibitor Sales and Share by Manufacturers (2015 and 2016)
2.2 Global Antidiabetic SGLT-2 Inhibitor Revenue and Share by Manufacturers (2015 and 2016)
2.3 Manufacturers Antidiabetic SGLT-2 Inhibitor Manufacturing Base Distribution and Product Type
2.4 Competitive Situation and Trends
  2.4.1 Expansions
  2.4.2 New Product Launches
  2.4.3 Acquisitions
  2.4.4 Other Developments

3 GLOBAL ANTIDIABETIC SGLT-2 INHIBITOR ANALYSIS BY REGION

3.1 Global Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Market Share by Region (2011-2021)
  3.1.1 Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Region (2011-2021)
  3.1.2 Global Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Region (2011-2021)
3.2 North America
  3.2.1 North America Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Price (2011-2021)
  3.2.2 North America Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Growth Rate (2011-2021)
3.3 Europe
  3.3.1 Europe Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Price (2011-2021)
  3.3.2 Europe Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Growth Rate (2011-2021)
3.4 China
  3.4.1 China Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Price (2011-2021)
  3.4.2 China Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Growth Rate (2011-2021)
3.5 Japan
  3.5.1 Japan Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Price (2011-2021)
  3.5.2 Japan Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Growth Rate (2011-2021)
3.6 India
  3.6.1 India Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Price (2011-2021)
  3.6.2 India Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Growth Rate (2011-2021)

4 GLOBAL ANTIDIABETIC SGLT-2 INHIBITOR ANALYSIS BY TYPE

4.1 Global Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Market Share and Growth Rate by Type (2011-2021)
  4.1.1 Global Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Type (2011-2021)
  4.1.2 Global Antidiabetic SGLT-2 Inhibitor Revenue, Market Share and Growth Rate by Type (2011-2021)
4.2 Type I Sales, Revenue, Price and Growth (2011-2020)
4.3 Type II Sales, Revenue, Price and Growth (2011-2020)
4.4 Type III Sales, Revenue, Price and Growth (2011-2020)

5 GLOBAL ANTIDIABETIC SGLT-2 INHIBITOR MARKET ANALYSIS BY APPLICATION

5.1 Global Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Application (2011-2021)
5.2 Major Regions Antidiabetic SGLT-2 Inhibitor Sales by Application in 2015 and 2016
  5.2.1 North America Antidiabetic SGLT-2 Inhibitor Sales by Application
  5.2.2 Europe Antidiabetic SGLT-2 Inhibitor Sales by Application
  5.2.3 China Antidiabetic SGLT-2 Inhibitor Sales by Application
  5.2.4 Japan Antidiabetic SGLT-2 Inhibitor Sales by Application
  5.2.5 India Antidiabetic SGLT-2 Inhibitor Sales by Application
  5.2.6 Antidiabetic SGLT-2 Inhibitor Sales by Application

6 GLOBAL ANTIDIABETIC SGLT-2 INHIBITOR MANUFACTURERS ANALYSIS

6.1 Anderson Hay & Grain Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Antidiabetic SGLT-2 Inhibitor Product Overview
    6.1.2.1 Type I
    6.1.2.2 Type II
    6.1.2.3 Type III
  6.1.3 Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Anderson Hay & Grain Inc. (2015 and 2016)
6.2 Border Valley
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Antidiabetic SGLT-2 Inhibitor Product Overview
    6.2.2.1 Type I
    6.2.2.2 Type II
    6.2.2.3 Type III
  6.2.3 Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Border Valley (2015 and 2016)
6.3 Sanofi
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Antidiabetic SGLT-2 Inhibitor Product Overview
    6.3.2.1 Type I
    6.3.2.2 Type II
    6.3.2.3 Type III
  6.3.3 Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Sanofi (2015 and 2016)
6.4 Johnson & Johnson
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Antidiabetic SGLT-2 Inhibitor Product Overview
    6.4.2.1 Type I
    6.4.2.2 Type II
  6.4.3 Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
6.5 Bristol-Myers Squibb
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Antidiabetic SGLT-2 Inhibitor Product Overview
    6.5.2.1 Type I
    6.5.2.2 Type II
  6.5.3 Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)
6.6 AstraZeneca
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Antidiabetic SGLT-2 Inhibitor Product Overview
    6.6.2.1 Type I
    6.6.2.2 Type II
  6.6.3 Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of AstraZeneca (2015 and 2016)
6.7 Boehringer Ingelheim
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Antidiabetic SGLT-2 Inhibitor Product Overview
    6.7.2.1 Type I
    6.7.2.2 Type II
  6.7.3 Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Boehringer Ingelheim (2015 and 2016)
6.8 GlaxoSmithKline
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Antidiabetic SGLT-2 Inhibitor Product Overview
    6.8.2.1 Type I
    6.8.2.2 Type II
  6.8.3 Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
6.9 Pfizer
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Antidiabetic SGLT-2 Inhibitor Product Overview
    6.9.2.1 Type I
    6.9.2.2 Type II
  6.9.3 Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Pfizer (2015 and 2016)
6.10 Takeda Pharmaceuticals
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Antidiabetic SGLT-2 Inhibitor Product Overview
    6.10.2.1 Type I
    6.10.2.2 Type II
  6.10.3 Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Takeda Pharmaceuticals (2015 and 2016)
6.11 Eli Lilly
6.12 Merck & Co.
6.13 Novo Nordisk

7 INDUSTRY POLICY ANALYSIS

8 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antidiabetic SGLT-2 Inhibitor
Figure Global Sales Market Share of Antidiabetic SGLT-2 Inhibitor by Type in 2015
Table Antidiabetic SGLT-2 Inhibitor Product Type of by Manufacturers
Table Antidiabetic SGLT-2 Inhibitor Sales Market Share by Application in 2015 and 2016
Figure North America Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
Figure China Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
Figure Europe Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
Figure Japan Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
Figure India Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
Figure Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
Table Global Antidiabetic SGLT-2 Inhibitor Sales and Revenue (2011-2021)
Figure Global Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2011-2021)
Figure Global Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2011-2021)
Table Global Antidiabetic SGLT-2 Inhibitor Sales of Key Manufacturers (2015 and 2016)
Table Global Antidiabetic SGLT-2 Inhibitor Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antidiabetic SGLT-2 Inhibitor Sales Share by Manufacturers
Figure 2016 Antidiabetic SGLT-2 Inhibitor Sales Share by Manufacturers
Table Global Antidiabetic SGLT-2 Inhibitor Revenue by Manufacturers (2015 and 2016)
Table Global Antidiabetic SGLT-2 Inhibitor Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Antidiabetic SGLT-2 Inhibitor Revenue Share by Manufacturers
Table 2016 Global Antidiabetic SGLT-2 Inhibitor Revenue Share by Manufacturers
Table Manufacturers Antidiabetic SGLT-2 Inhibitor Manufacturing Base Distribution and Product Type
Table Global Antidiabetic SGLT-2 Inhibitor Sales Market by Region (2011-2021)
Figure Global Antidiabetic SGLT-2 Inhibitor Sales Market by Region (2011-2021)
Figure Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Region (2011-2021)
Table Global Antidiabetic SGLT-2 Inhibitor Revenue Market by Region (2011-2021)
Table Global Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Region (2011-2021)
Table North America Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Price (2011-2021)
Figure North America Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Growth Rate (2011-2021)
Table Europe Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Price (2011-2021)
Figure Europe Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Growth Rate (2011-2021)
Table China Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Price (2011-2021)
Figure China Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Growth Rate (2011-2021)
Table Japan Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Price (2011-2021)
Figure Japan Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Growth Rate (2011-2021)
Table India Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Price (2011-2021)
Figure India Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Growth Rate (2011-2021)
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Price (2011-2021)
Figure Antidiabetic SGLT-2 Inhibitor Sales, Revenue and Growth Rate (2011-2021)
Table Global Antidiabetic SGLT-2 Inhibitor Sales by Type (2011-2021)
Table Global Antidiabetic SGLT-2 Inhibitor Sales Share by Type (2011-2021)
Figure Sales Market Share of Antidiabetic SGLT-2 Inhibitor by Type (2011-2021)
Figure Global Antidiabetic SGLT-2 Inhibitor Sales Growth Rate by Type (2011-2021)
Table Global Antidiabetic SGLT-2 Inhibitor Revenue by Type (2011-2021)
Table Global Antidiabetic SGLT-2 Inhibitor Revenue Share by Type (2011-2021)
Figure Global Antidiabetic SGLT-2 Inhibitor Revenue Growth Rate by Type (2011-2021)
Figure Type I Sales, Revenue and Growth (2011-2021)
Figure Type I Price Trend (2011-2021)
Figure Type II Sales, Revenue and Growth (2011-2021)
Figure Type II Price Trend (2011-2021)
Figure Type III Sales, Revenue and Growth (2011-2021)
Figure Type III Price Trend (2011-2021)
Table Global Antidiabetic SGLT-2 Inhibitor Sales by Application (2011-2021)
Table Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Application (2011-2021)
Figure Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Application in 2015
Figure Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Application in 2021
Table North America Antidiabetic SGLT-2 Inhibitor Sales by Application (2015 and 2016)
Table Europe Antidiabetic SGLT-2 Inhibitor Sales by Application (2015 and 2016)
Table China Antidiabetic SGLT-2 Inhibitor Sales by Application (2015 and 2016)
Table Japan Antidiabetic SGLT-2 Inhibitor Sales by Application (2015 and 2016)
Table India Antidiabetic SGLT-2 Inhibitor Sales by Application (2015 and 2016)
Table Antidiabetic SGLT-2 Inhibitor Sales by Application (2015 and 2016)
Table Global Antidiabetic SGLT-2 Inhibitor Sales Growth Rate by Application (2011-2021)
Figure Global Antidiabetic SGLT-2 Inhibitor Sales Growth Rate by Application (2011-2021)
Table Anderson Hay & Grain Inc. Basic Information List
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Anderson Hay & Grain Inc. (2015 and 2016)
Table Border Valley Basic Information List
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Border Valley (2015 and 2016)
Table Sanofi Basic Information List
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Sanofi (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table Bristol-Myers Squibb Basic Information List
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)
Table AstraZeneca Basic Information List
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of AstraZeneca (2015 and 2016)
Table Boehringer Ingelheim Basic Information List
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Boehringer Ingelheim (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Pfizer Basic Information List
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Pfizer (2015 and 2016)
Table Takeda Pharmaceuticals Basic Information List
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Takeda Pharmaceuticals (2015 and 2016)
Table Eli Lilly Basic Information List
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Eli Lilly (2015 and 2016)
Table Merck & Co. Basic Information List
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Merck & Co. (2015 and 2016)
Table Novo Nordisk Basic Information List
Table Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price of Novo Nordisk (2015 and 2016)